Delphine Diagnostics continues to support the rapid growth of New Jersey’s healthcare innovation ecosystem through the development of AI-enabled diagnostic solutions focused on early detection and improved patient outcomes.
As the state’s life sciences community continues to expand, Delphine remains committed to collaborating with industry partners to advance innovative technologies that address critical healthcare challenges.